High Velocity Nasal Insufflation
High Velocity Nasal Insufflation is a medical device with 8 clinical trials. Currently 3 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 1 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
100.0%
1 of 1 finished
0.0%
0 ended early
3
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Noninvasive Support for Acute Respiratory Failure in Guillain-Barré Syndrome
Noninvasive Support Methods for Acute Respiratory Failure of Community-acquired Pneumonia
High Velocity Nasal Insufflation Versus Continuous Positive Airway Pressure in COVID 19 Pneumonic Patients
High Flow Nasal Cannula Versus High Velocity Nasal Insufflation for Weaning
Comparison Between Four Weaning Methods from High-velocity Nasal Insufflation Device in Acute Hypoxemic Respiratory Failure
Clinical Trials (8)
Noninvasive Support for Acute Respiratory Failure in Guillain-Barré Syndrome
Noninvasive Support Methods for Acute Respiratory Failure of Community-acquired Pneumonia
High Velocity Nasal Insufflation Versus Continuous Positive Airway Pressure in COVID 19 Pneumonic Patients
High Flow Nasal Cannula Versus High Velocity Nasal Insufflation for Weaning
Comparison Between Four Weaning Methods from High-velocity Nasal Insufflation Device in Acute Hypoxemic Respiratory Failure
HVNI for Successful Weaning in Respiratory Failure
Role of HVNI in Severe Chest Trauma
Evaluation of High Velocity Nasal Insufflation in Management of Respiratory Failure in Patients With Overlap Syndrome
All 8 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 8